Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
9.70
+0.80 (9.06%)
At close: Nov 4, 2026, 4:00 PM EST
9.57
-0.13 (-1.29%)
After-hours: Nov 4, 2026, 6:02 PM EST

Teladoc Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-154.82-200.32-1,001-220.37-13,660-428.79
Depreciation & Amortization
227.26208.82249.81265.76221.69219.62
Other Amortization
150.64167.62133.0482.9646.1-
Asset Writedown & Restructuring Costs
-71.76790-13,403-
Loss (Gain) From Sale of Investments
------5.9
Stock-Based Compensation
51.4480.41145.95201.55217.85302.59
Provision & Write-off of Bad Debts
1.6603.84.692.8210.6
Other Operating Activities
-4.09-35.018.653.795.95139.86
Change in Accounts Receivable
-21.525.13-0.38-10.25-49.06-11.17
Change in Inventory
7.550.4-9.7524.114.8-19.49
Change in Accounts Payable
-5.511.45-10.37-4.181.881.19
Change in Unearned Revenue
-9.56-19.76-18.25-4.915.2420.55
Change in Other Net Operating Assets
25.29-16.142.426.89-31.25-35.06
Operating Cash Flow
268.38294.36293.68350.02189.29193.99
Operating Cash Flow Growth
-8.25%0.23%-16.10%84.91%-2.42%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-6.42-8.89-10.79-11.46-16.48-8.53
Cash Acquisitions
--81.9----78.66
Sale (Purchase) of Intangibles
-135.84-148.13-113.26-144.88-156.28-55.4
Investment in Securities
-1-27.14--2.5160.9
Other Investing Activities
00.06-02.518.72
Investing Cash Flow
-143.25-266-124.05-156.35-167.74-72.98

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--550.63----
Net Debt Issued (Repaid)
--550.63----
Issuance of Common Stock
2.793.098.3111.1312.3942.59
Other Financing Activities
-2.85-4.11-0-0.28-5.89-1.64
Financing Cash Flow
-0.05-551.658.3110.856.540.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.416.06-3.290.97-3.34-1.8
Net Cash Flow
123.66-517.24174.65205.4924.7160.16

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
261.96285.46282.89338.56172.81185.46
Free Cash Flow Growth
-6.48%0.91%-16.44%95.91%-6.82%-
Free Cash Flow Margin
10.61%11.28%11.01%13.01%7.18%9.12%
Free Cash Flow Per Share
1.461.621.662.061.071.18
Levered Free Cash Flow
195.67226.14229.78303.95176.62241.62
Unlevered Free Cash Flow
208.4238.46244.65317.88190.34292.34

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
12.615.0117.3217.4217.3618.84
Cash Income Tax Paid
7.738.758.957.242.513.97
Change in Working Capital
-3.711.08-36.3211.64-48.39-43.99
SEC Filings: 10-K · 10-Q